Výsledky vyhledávání - "Ye Sheng-Long"

Akademický článek

Identifying and prioritizing strategies for comprehensive liver cancer control in Asia

Autor: Bridges John FP, Gallego Gisselle, Kudo Masatoshi, Okita Kiwamu, Han Kwang-Hyub, Ye Sheng-Long, Blauvelt Barri M

Publikováno v: BMC Health Services Research, Vol 11, Iss 1, p 298 (2011)

Abstract Background Liver cancer is both common and burdensome in Asia. Effective liver cancer control, however, is hindered by a complex etiology and a lack of coordination across clinical disciplines. We sought to identify strategies for inclusion

Externí odkaz: https://doaj.org/article/f0ffa5ec03c64a1f8f379f240467d05c

Zobrazit plný text záznamu

Akademický článek

Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression

Autor: Xia Yun-Hong, Chen Rong-Xin, Xue Tong-Chun, Ye Sheng-Long

Publikováno v: Journal of Experimental & Clinical Cancer Research, Vol 29, Iss 1, p 172 (2010)

Abstract Background Specific gene expression is tightly regulated by various transcription factors. Osteopontin (OPN) is a phosphoprotein that mediates hepatocellular carcinoma (HCC) progression and metastasis. However, the mechanism of OPN up-regula

Externí odkaz: https://doaj.org/article/cd3ab31e33cd460abaad4881f0b06aa8

Zobrazit plný text záznamu

Akademický článek

Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma

Autor: Lim Ho-Yeong, Hsu Chiun, Han Kwang-Hyub, Furuse Junji, Chen Pei-Jer, Yeo Winnie, Moon Hanlim, Qin Shukui, Yeoh Ee-Min, Ye Sheng-Long

Publikováno v: BMC Cancer, Vol 10, Iss 1, p 620 (2010)

Abstract The largest burden of hepatocellular carcinoma (HCC) lies in Asia, secondary to hepatitis B virus (HBV) infection. Improved survival with sorafenib has fostered new research but many challenges remain in designing clinical trials. The diseas

Externí odkaz: https://doaj.org/article/9536b460f6164a269b5030f7d318d0cf

Zobrazit plný text záznamu